Studies have shown that the subjects with diabetes (47), obesity (44), or MetS (48), had an increased activity of CYP2E1, which might be associated with both hepatic toxin metabolism (49, 50) and the development of liver fibrosis (43). This evidence concerns the gene CYP2E1 and Obesity.